Clinical trial · Observational
Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A multicenter retrospective observational study among children with type 1 diabetes will be performed. The Objective of this study will be to determine a) the association between the increase in Hba1c in children with type 1 diabetes and confinement due to the COVID 19 pandemic. b) the association between the frequency of patient care during social confinement and the Hba1c values. Different centers from Latin America including Argentina, Peru, Panama, Chile, and Ecuador will participate in this study. Children younger than 17 years with a diagnosis of type 1 diabetes prior to 2018 will be included. Data from the medical records of the participating centers will be collected on the Hb A1c value before and after confinement (6 months completed). The initial (base) value will be taken as a value of HbA1c registered in the patient's Clinical History for the year 2018, 2019, and 2020 pre and post quarantine (Sep-Oct-Nov) 2020, considering compliance with six months of quarantine. Hb A1c should have been performed in the same institution or with the same methods in order to avoid bias.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Childhood ALL | Childhood Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
| Type1diabetes | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Patient with type 1 diabetes
- description
- Children younger than 17 years with a diagnosis of type 1 diabetes prior to 2018 will be included.
Primary outcomes (1)
- measure
- Hb A1C pre and post Confinement in Latin American children with Type 1 Diabetes
- timeFrame
- six months
- description
- The increase in Hba1c in children with type 1 diabetes and confinement due to the COVID 19 pandemic
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 2 Years
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: Children with type 1 diabetes younger than 17 years - Exclusion Criteria: pregnancy, kidney failure, treatments that alter hydrocarbon metabolism (corticosteroids, chemotherapy, etc.), and chronic iron deficiency pathologies that alter the value of HbA1c. \-
References
Publications (0)
Data not yet available